You are here

Article info

Article menu
Download PDFPDF
Clinical science
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab

Authors

  1. Correspondence to Dr Jeffrey S Heier, Department of Retina, Ophthalmic Consultants of Boston, 50 Staniford Street, Suite 600, Boston, MA 02114, USA; jsheier{at}eyeboston.com
View Full Text

Citation

Cho H, Shah CP, Weber M, et al
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
British Journal of Ophthalmology 2013;97:1032-1035.

Publication history

  • Received March 5, 2013
  • Revised April 26, 2013
  • Accepted May 20, 2013
  • First published June 13, 2013.
Online issue publication 
November 24, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions